FDA Inspection 1085723 — Collegium Pharmaceutical, Inc
The FDA completed an inspection of Collegium Pharmaceutical, Inc on March 15, 2019 in Stoughton, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 15, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Stoughton, MA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)